3B BlackBio DxBOM:532067 -0.97%63 Operating Margin % is 12.99% as of Mar. 2026, which is 67% below its 10-year median of 39.94. GuruFocus rates BOM:532067 with a GF Score™ of 63/100 and a GF Value™ of ₹2,097.99 (Possible Value Trap). The stock has 2 warning signs investors should review. Among 943 Biotechnology companies, 3B BlackBio Dx ranks better than 94.91% on this metric.
3B BlackBio Dx Ltd operating margin has been in a 5-year decline. The average rate of decline per year is -7.4%.
The historical rank and industry rank for 3B BlackBio Dx's Operating Margin % or its related term are showing as below:
BOM:532067'
s Operating Margin % Range Over the Past 10 Years
Min: 13.07 Med: 39.94 Max: 65.88
Current: 36.13
BOM:532067's Operating Margin % is ranked better than 94.91% of 943
companies
in the Biotechnology industry
Industry Median: -86.89
vs BOM:532067: 36.13
3B BlackBio Dx's 5-Year Average Operating Margin % Growth Rate was -7.40% per year.
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
3B BlackBio Dx Operating Margin % Related Terms
3B BlackBio Dx Operating Margin % Historical Data
* Premium members only.
The historical data trend for 3B BlackBio Dx's Operating Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:532067 vs VRTX, REGN, ALNY: Operating Margin % Comparison
For the Biotechnology subindustry, 3B BlackBio Dx's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
3B BlackBio Dx Operating Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, 3B BlackBio Dx's Operating Margin % distribution charts can be found below:
* The bar in red indicates where 3B BlackBio Dx's Operating Margin % falls into.
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
3B BlackBio Dx's Operating Margin % for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
3B BlackBio Dx (BOM:532067) has a Operating Margin % of 12.99% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on 3B BlackBio Dx and its competitors. This is 67% below median its historical median of 39.94. Over the past decade, 3B BlackBio Dx's Operating Margin % has ranged from 13.07 to 65.88. According to the industry distribution chart, 3B BlackBio Dx ranks #48 out of 943 companies in the Biotechnology industry, placing it in the top 5.1%.
Is 3B BlackBio Dx's Operating Margin % too high?
3B BlackBio Dx's current Operating Margin % of 12.99% is 67% below median its 10-year median of 39.94. Over the past 10 years, this metric has ranged from a low of 13.07 to a high of 65.88. Based on the distribution chart, 3B BlackBio Dx ranks #48 out of 943 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, 3B BlackBio Dx has a GF Score™ of 63/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does 3B BlackBio Dx's Operating Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, 3B BlackBio Dx ranks #48 out of 943 companies for Operating Margin %. This places 3B BlackBio Dx in the top 5% of its industry — outperforming the majority of peers. Historically, 3B BlackBio Dx's own Operating Margin % has ranged from 13.07 to 65.88 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Biotechnology company?
A good Operating Margin % depends on the Biotechnology industry context. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on 3B BlackBio Dx and its competitors. 3B BlackBio Dx's current Operating Margin % is 12.99%, which is 67% below median its own 10-year median of 39.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 3B BlackBio Dx stock overvalued right now?
Based on GuruFocus' analysis, 3B BlackBio Dx (BOM:532067) is currently considered Possible Value Trap. The stock's GF Value™ is ₹2,097.99, compared to a current price of ₹1,162.10 — trading 44.6% below its estimated fair value. The current Operating Margin % is 12.99%, which is 67% below median its 10-year median of 39.94. 3B BlackBio Dx's overall GF Score™ is 63/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For 3B BlackBio Dx (BOM:532067), the current Operating Margin % is 12.99% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is 3B BlackBio Dx (BOM:532067) Overvalued in 2026?
Based on GuruFocus' analysis, 3B BlackBio Dx stock appears to be undervalued.
The current stock price of ₹1,162.10 is trading 44.6% below its estimated GF Value™ of ₹2,097.99.
GuruFocus considers 3B BlackBio Dx to be Possible Value Trap.
Key valuation signals for BOM:532067:
Operating Margin %: 12.99% (67% below median its 10-year median of 39.94)
GF Value™: ₹2,097.99 vs. price of ₹1,162.10 (44.6% below fair value)
No single metric tells the full story. See the BOM:532067 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
3B BlackBio Dx Ltd is an Indian company specializing in PCR-based Molecular Diagnostic Kits. The company is involved in designing, developing, manufacturing, and commercializing PCR-based Molecular Diagnostic kits, PCR Enzymes, and PCR Reagents.
63GF Score
Get the complete analysis for BOM:532067
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:532067 has been successfully added to your 
